Suppr超能文献

一种新型基于人工智能的盲肠识别系统对筛查结肠镜检查中腺瘤检测指标的影响。

Effect of a novel artificial intelligence-based cecum recognition system on adenoma detection metrics in a screening colonoscopy setting.

作者信息

Hsu Wen-Feng, Chang Wei-Yuan, Kuo Chen-Ya, Chang Li-Chun, Lin Hsuan-Ho, Wu Ming-Shiang, Chiu Han-Mo

机构信息

Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.

Department of Internal Medicine, Fu Jen Catholic University Hospital, New Taipei City, Taiwan.

出版信息

Gastrointest Endosc. 2025 Feb;101(2):452-455. doi: 10.1016/j.gie.2024.09.019. Epub 2024 Sep 18.

Abstract

BACKGROUND AND AIMS

Cecal intubation in colonoscopy relies on self-reporting. We developed an artificial intelligence-based cecum recognition system (AI-CRS) for post-hoc verification of cecal intubation and explored its impact on adenoma metrics.

METHODS

Quality metrics, including cecal intubation rate (CIR), adenoma detection rate (ADR), and other ADR-related metrics, were compared both before (2015-2018) and after (2019-2022) the implementation of the AI-CRS.

RESULTS

Although the CIR did not change significantly after the implementation of the AI-CRS, the ADR and advanced ADR significantly increased. Although the ADR significantly increased in all segments, the most significant increase in advanced ADR was observed in the proximal colon. Implementation of the AI-CRS was associated with a higher likelihood of detecting adenoma (adjusted odds ratio, 1.35; 95% confidence interval, 1.26-1.45) and advanced adenoma (adjusted odds ratio, 1.23; 95% confidence interval, 1.07-1.41), respectively.

CONCLUSIONS

Implementation of a post-hoc verification of cecal intubation using an AI-CRS significantly improved various adenoma metrics in screening colonoscopy.

摘要

背景与目的

结肠镜检查中的盲肠插管依赖于自我报告。我们开发了一种基于人工智能的盲肠识别系统(AI-CRS),用于对盲肠插管进行事后验证,并探讨其对腺瘤指标的影响。

方法

比较了在实施AI-CRS之前(2015 - 2018年)和之后(2019 - 2022年)的质量指标,包括盲肠插管率(CIR)、腺瘤检出率(ADR)以及其他与ADR相关的指标。

结果

虽然实施AI-CRS后CIR没有显著变化,但ADR和高级别ADR显著增加。尽管所有节段的ADR均显著增加,但近端结肠的高级别ADR增加最为显著。实施AI-CRS分别与检测到腺瘤(调整优势比,1.35;95%置信区间,1.26 - 1.45)和高级别腺瘤(调整优势比,1.23;95%置信区间,1.07 - 1.41)的可能性更高相关。

结论

使用AI-CRS对盲肠插管进行事后验证显著改善了筛查结肠镜检查中的各种腺瘤指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验